Table 2.

Resistance rate of different isolates from inpatient and outpatient settings

Isolates	Antibiotics
	AMX		CZO		CRO		NAL		NOR		SXT		GEN		NIT		CTX		VAN		PEN		ERY
	IN	OUT	IN	OUT	IN	OUT	IN	OUT	IN	OUT	IN	OUT	IN	OUT	IN	OUT	IN	OUT	IN	OUT	IN	OUT	IN	OUT
E. coli (n* = 91/594)	75.8	67.1	54.9	37.8	36.2	20.7	85.7	74.9	51.6	37.7	62.6	54.2	19.7	15.4	4.3	2.6	31.8	18.1	–	–	–	–	–	–
K. pneumonia (n* = 6/30)	–	–	66.6	30	66.6	10	33.3	20	16.6	13.3	50	26.6	50	3.3	16.6	10	50	10	–	–	–	–	–	–
Enterococcus spp. (n* = 9/14)	55.5	14.2	–	–	–	–	–	–	33.3	50	0	14.2	–	–	0	7.1	–	–	0	0	100	57.1	88.8	57.1
S. saprophyticus (n* = 4/16)	–	–	25	0	0	6.2	0	6.2	–	–	25	12.5	–	–	25	0	–	–	25	0	75	62.5	0	0
Acinetobacter spp. (n* = 4/14)	50	35.7	100	64.2	25	7.1	25	14.2	25	7.1	50	14.2	–	–	75	78.5	25	7.1	–	–	–	–	–	–
Proteus spp. (n* = 4/19)	0	63.1	0	89.4	0	0	0	31.5	0	10.5	25	31.5	0	10.5	–	–	0	0	–	–	–	–	–	–
K. oxytoca (n* = 3/7)	0	28.5	0	100	0	42.8	0	57.1	0	42.8	0	28.5	0	28.5	0	0	0	42.8	–	–	–	–	–	–
Citrobacter spp. (n*=1/8)	0	100	0	87.5	0	25	0	12.5	0	12.5	0	12.5	0	12.5	0	12.5	0	25	–	–	–	–	–	–
S. aureus (n*=1/6)	0	33.3	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	0	100	83.3	0	16.6
Enterobacter spp. (n*=1/7)	0	71.4	0	71.4	0	14.2	0	14.2	0	14.2	–	–	0	0	0	28.5	0	14.2	–	–	–	–	–	–

n* inpatient/outpatient, IN inpatient, OUT outpatient, AMX amoxicillin, CZO cefazolin, CRO ceftriaxone, NAL nalidixic acid, NOR norfloxacin, SXT cotrimoxazole, GEN gentamicin, NIT nitrofurantoin, CTX cefotaxime, VAN vancomycin, PEN penicillin, ERY erythromycin